Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?

JN O'Donnell, V Putra, TP Lodise - … : The Journal of Human …, 2021 - Wiley Online Library
This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …

Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: How viable are the current options?

JN O'Donnell, V Putra, TP Lodise - Pharmacotherapy, 2021 - pubmed.ncbi.nlm.nih.gov
This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem-resistant Acinetobacter baumannii infections. Despite …

Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: How viable are the current options?

JN O'Donnell, V Putra, TP Lodise - Pharmacotherapy, 2021 - europepmc.org
This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem-resistant Acinetobacter baumannii infections. Despite …

Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: how viable are the current options?

JN O'Donnell, V Putra, TP Lodise - 2021 - cabidigitallibrary.org
This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem-resistant Acinetobacter baumannii infections. Despite …